GCL
APGN

Glazer Capital LLC’s Apexigen, Inc. Common Stock APGN Stock Holding History

Glazer Capital LLC’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-271,178
Closed -$2.75M – 748
2022
Q2 		$2.75M Sell
271,178
-7,554
-3% -$76.5K 0.07% 293
2022
Q1 		$2.81M Buy
278,732
+264,185
+1,816% +$2.65M 0.08% 225
2021
Q4 		$146K Buy
+14,547
New +$145K ﹤0.01% 636

Other funds holding APGN

DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Glazer Capital LLC's APGN Position: Q3 2022 in Review

Glazer Capital LLC sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2022, closing a stake of 271,178 shares — an estimated $2.75M sold.

Glazer Capital LLC first reported a position in APGN in Q4 2021 and held it in 3 quarters. The position peaked at $2.81M in Q1 2022. 18 funds tracked by Wall St. Rank hold APGN as of Q3 2022.

  • Glazer Capital LLC reported no remaining Apexigen, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Glazer Capital LLC sold 271,178 Apexigen, Inc. Common Stock shares in Q3 2022, an estimated $2.75M.
  • Glazer Capital LLC first reported a position in Apexigen, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Glazer Capital LLC's Apexigen, Inc. Common Stock position peaked at $2.81M in Q1 2022.
  • 18 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2022.

Based on Glazer Capital LLC's 13F filing for Q3 2022, filed 14 Nov 2022.